Dose Reduction of Preoperative Radiotherapy in Myxoid Liposarcoma: A Nonrandomized Controlled Trial

IMPORTANCE: Currently, preoperative radiotherapy for all soft-tissue sarcomas is identical at a 50-Gy dose level, which can be associated with morbidity, particularly wound complications. The observed clinical radiosensitivity of the myxoid liposarcoma subtype might offer the possibility to reduce m...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:JAMA Oncol
Main Authors: Lansu, Jules, Bovée, Judith V. M. G., Braam, Pètra, van Boven, Hester, Flucke, Uta, Bonenkamp, Johannes J., Miah, Aisha B., Zaidi, Shane H., Thway, Khin, Bruland, Øyvind S., Baldini, Elizabeth H., Jebsen, Nina L., Scholten, Astrid N., van den Ende, Piet L. A., Krol, Augustinus D. G., Ubbels, Jan F., van der Hage, Jos A., van Werkhoven, Erik, Klomp, Houke M., van der Graaf, Winette T. A., van Coevorden, Frits, Schrage, Yvonne, van Houdt, Winan J., Haas, Rick L.
Formato: Artigo
Idioma:Inglês
Publicado em: American Medical Association 2020
Assuntos:
Original Investigation
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7662477/
https://ncbi.nlm.nih.gov/pubmed/33180100
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamaoncol.2020.5865
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados